A multicentric, double-blind, randomised-controlled trial (RCT) of carnitine orotate complex in diabetic patients with non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Bae, J. [1 ]
Lee, W. [2 ]
Yoon, K. [3 ]
Park, J. [4 ]
Son, H. [4 ]
Han, K. [4 ]
Lee, K. [5 ]
Woo, J. -T. [4 ]
Lee, M. -K. [6 ]
机构：
[1] Samsung Changwon Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[2] Kangbuk Samsung Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[3] Kangnam St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[4] Eulji Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea
[5] Dept Internal Med, Div Endocrinol & Metab, Suwon, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
858
引用
收藏
页码：S349 / S350
页数：2
相关论文
共 50 条
  • [1] A MULTICENTRIC, DOUBLE-BLIND, RANDOMISED-CONTROLLED TRIAL (RCT) OF HIGH DOSE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Ratziu, V.
    De Ledinghen, V.
    Oberti, F.
    Mathurin, P.
    Wartelle-Bladou, C.
    Renou, C.
    Spenard, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S21 - S21
  • [2] Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Chong, Clara Yieh Lin
    Orr, David
    Plank, Lindsay D.
    Vatanen, Tommi
    O'Sullivan, Justin M.
    Murphy, Rinki
    NUTRIENTS, 2020, 12 (04)
  • [3] A PLACEBO-CONTROLLED, MULTICENTER, DOUBLE-BLIND, RANDOMISED TRIAL OF EMRICASAN IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RAISED TRANSAMINASES
    Shiffman, M.
    Freilich, B.
    Vuppalanchi, R.
    Watt, K.
    Burgess, G.
    Morris, M.
    Sheedy, B.
    Schiff, E.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S282 - S282
  • [4] Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
    Kessoku, Takaomi
    Imajo, Kento
    Kobayashi, Takashi
    Ozaki, Anna
    Iwaki, Michihiro
    Honda, Yasushi
    Kato, Takayuki
    Ogawa, Yuji
    Tomeno, Wataru
    Kato, Shingo
    Higurashi, Takuma
    Yoneda, Masato
    Kirikoshi, Hiroyuki
    Kubota, Kazumi
    Taguri, Masataka
    Yamanaka, Takeharu
    Usuda, Haruki
    Wada, Koichiro
    Kobayashi, Noritoshi
    Saito, Satoru
    Nakajima, Atsushi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (11): : 996 - 1007
  • [5] Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
    Stanley, Takara L.
    Fourman, Lindsay T.
    Feldpausch, Meghan N.
    Purdy, Julia
    Zheng, Isabel
    Pan, Chelsea S.
    Aepfelbacher, Julia
    Buckless, Colleen
    Tsao, Andrew
    Kellogg, Anela
    Branch, Karen
    Lee, Hang
    Liu, Chia-Ying
    Corey, Kathleen
    Chung, Raymond T.
    Torriani, Martin
    Kleiner, David E.
    Hadigan, Colleen M.
    Grinspoon, Steven K.
    LANCET HIV, 2019, 6 (12): : E821 - E830
  • [6] Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
    Mofidi, Fatemeh
    Poustchi, Hossein
    Yari, Zahra
    Nourinayyer, Babak
    Merat, Shahin
    Sharafkhah, Maryam
    Malekzadeh, Reza
    Hekmatdoost, Azita
    BRITISH JOURNAL OF NUTRITION, 2017, 117 (05) : 662 - 668
  • [7] The nanocurcumin reduces appetite in obese patients with non-alcoholic fatty liver disease (nafld): a double-blind randomized placebo-controlled clinical trial
    Jazayeri-Tehrani, Seyed Ali
    Rezayat, Seyed Mahdi
    Mansouri, Siavash
    Qorbani, Mostafa
    Alavian, Seyed Moayed
    Daneshi-Maskooni, Milad
    Hosseinzadeh-Attar, Mohammad-Javad
    NANOMEDICINE JOURNAL, 2018, 5 (02) : 67 - 76
  • [8] Flaxseed oil in the context of a weight loss programme ameliorates fatty liver grade in patients with non-alcoholic fatty liver disease: a randomised double-blind controlled trial
    Rezaei, Shahla
    Sasani, Mohammad Reza
    Akhlaghi, Masoumeh
    Kohanmoo, Ali
    BRITISH JOURNAL OF NUTRITION, 2020, 123 (09) : 994 - 1002
  • [9] Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis
    Safadi, Rifaat
    Braun, Marius
    Francis, Adi
    Milgrom, Yael
    Massarwa, Muhammad
    Hakimian, David
    Hazou, Wadi
    Issachar, Assaf
    Harpaz, Zivit
    Farbstein, Motti
    Itzhak, Inbal
    Lev-Cohain, Naama
    Bareket-Samish, Avital
    Silverman, Michael H.
    Fishman, Pnina
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1405 - 1415
  • [10] Prebiotic supplementation with inulin following metronidazole therapy achieves greater ALT reduction in Non-Alcoholic Fatty Liver Disease (NAFLD): A randomised double-blind placebo controlled trial
    Orr, David W.
    Murphy, Rinki
    HEPATOLOGY, 2015, 62 : 1268A - 1269A
12345